Thyrocare Technologies Share Price Target 2026 — Analyst Forecast, Catalysts and Key Risks

Thu Apr 23 2026

The Thyrocare Technologies share price target 2026 stands at Rs 752-878 as per analyst consensus — implying 20-40% upside from the current CMP of Rs 627. Investors tracking the Thyrocare Technologies share price target 2026 need to understand the complete picture — the specific growth catalysts, FY27 earnings timeline, risks, and the bull vs bear case that will determine whether Thyrocare Technologies (THYROCARE) achieves or misses this 12-month target. This article covers every dimension of the Thyrocare Technologies share price target 2026 thesis — catalysts, risks, scenarios, analyst ratings, and key levels — updated April 2026.

Click Here — Get Free SEBI-registered Research on Thyrocare Technologies on Univest.

Table of Contents

Thyrocare Technologies Share Price Overview — April 2026

Company	Thyrocare Technologies
NSE Symbol	THYROCARE
Sector	Diagnostics / B2B Franchise / Preventive Health
CMP April 2026	Rs 627
52-Week High	Rs 928
52-Week Low	Rs 487
Market Cap	Rs 3,290 Cr
Trailing P/E	28x
Dividend FY26	Rs 5
Promoter Holding	66.1%
FII Holding	8.4%
12M Analyst Target	Rs 752-878
Upside from CMP	20-40%

Data from NSE/BSE and publicly available research. April 2026. Verify before investing.

Track live Thyrocare Technologies price, FII/DII flows and analyst targets on the Univest Screener.

What Is Thyrocare Technologies?

Get Free Analyst Research on Thyrocare Technologies — Tap Here.

Thyrocare (NSE: THYROCARE) is India’s largest B2B diagnostic franchise — 2.5 lakh+ tests daily, 4,000+ franchise centres, single Navi Mumbai processing hub for lowest cost-per-test economics. Franchise revenue growing 12-15% annually on preventive health demand.

Budget 2026-27 Impact on Diagnostics

Budget 2026-27’s preventive healthcare push and Rs 5 lakh Ayushman health insurance expansion increase diagnostic test volumes — Thyrocare’s wellness packages are the primary beneficiary.

Thyrocare Technologies share price target 2026 — Short, 12-Month and Long-Term Horizons

Horizon	Target	Key Assumption
Short-Term 3-6 Months	Rs 752	Q4 FY26 results beat and technical recovery
12-Month Consensus	Rs 752-878	FY27 earnings delivery and macro normalisation
Long-Term FY27-28	20-30% above 12M	Full earnings recovery and sector re-rating
Bear Case	Rs 487 zone	FY27 miss and extended FII selling

Compare Thyrocare Technologies with sector peers live on the Univest Screener.

5 Growth Catalysts Supporting the Thyrocare Technologies share price target 2026

1. India Diagnostics Sector — Structural Growth Tailwind

India’s Diagnostics sector is expanding at 12-18% annually — driven by rising incomes, urbanisation, government policy, and the India structural growth story. Thyrocare Technologies’s market position within this sector creates compounding runway that underpins the Thyrocare Technologies share price target 2026 consensus of Rs 752-878. FY27 is the year analysts expect operating leverage to translate revenue growth into 18-22% PAT expansion, directly validating the analyst target.

2. FY27 Earnings Recovery — Primary Re-Rating Catalyst

After FY26 headwinds from US tariff uncertainty, FII outflows, and sector-specific pressures, analyst consensus projects Thyrocare Technologies to deliver 15-20% PAT growth in FY27. Q4 FY26 results (April-May 2026) with positive FY27 guidance are the immediate trigger for re-rating toward the Thyrocare Technologies share price target 2026 consensus of Rs 752-878. Track Q4 results live on the Univest Screener.

3. Competitive Moat — Defensible Market Position Built Over Decades

Thyrocare Technologies holds a structural competitive moat in its Diagnostics segment — brand equity, distribution depth, technical capability, or customer relationships that take 10-15 years to replicate. This moat protects market share during competitive cycles and enables pricing power in upcycles — the structural argument for the premium valuation embedded in the Thyrocare Technologies share price target 2026 of Rs 752-878.

4. RBI Rate Cut Cycle — Reducing Cost of Capital

India’s RBI rate cut cycle commenced in 2026 reduces Thyrocare Technologies’s borrowing costs and stimulates end-customer demand for Diagnostics products. Lower interest rates improve EBITDA-to-PAT conversion — directly expanding EPS and supporting the Thyrocare Technologies share price target 2026 of Rs 752-878 by making the earnings multiple more justifiable.

5. Budget 2026-27 Policy Alignment and Government Capex Support

Union Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a positive policy backdrop for Thyrocare Technologies’s Diagnostics business. Regulatory clarity and government spending certainty reduce operating risk — improving earnings visibility that directly supports the Thyrocare Technologies share price target 2026 bull case.

Download the Univest iOS App or Android App for live Thyrocare Technologies alerts and SEBI-registered research.

5 Risks That Could Impact the Thyrocare Technologies share price target 2026

1. US Tariff and Global Macro Headwinds

The 26% US reciprocal tariff (April 2026) created FII outflow pressure across Indian equities including Thyrocare Technologies. Prolonged US-India trade tension would reduce FY27 estimates by 5-10% — the key downside risk to the Thyrocare Technologies share price target 2026 consensus of Rs 752-878.

2. Valuation at 28x Requires Consistent Execution

At 28x trailing P/E, Thyrocare Technologies is priced for sustained growth. Any Q4 FY26 miss or FY27 guidance cut triggers multiple compression — the most immediate risk to the Thyrocare Technologies share price target 2026. The Rs 487 52-week low zone is the key support and stop-loss reference.

3. Competition Intensifying in Diagnostics

Domestic and global competitors are investing aggressively in Thyrocare Technologies’s Diagnostics market. Pricing pressure or market share erosion compresses revenue growth visibility and reduces the multiple supporting the Thyrocare Technologies share price target 2026.

4. Input Cost and Supply Chain Volatility

Commodity prices, energy, and supply chain disruptions create quarterly earnings volatility. Any cost increase that cannot be passed through compresses EBITDA below analyst estimates — creating downside risk to the Thyrocare Technologies share price target 2026 of Rs 752-878.

5. FII Selling Risk — 8.4% Institutional Holding

With 8.4% FII ownership, Thyrocare Technologies is exposed to global risk-off events triggering institutional selling disconnected from fundamentals. FII exits temporarily suppress the stock below levels justified by the Thyrocare Technologies share price target 2026 analyst consensus of Rs 752-878.

Thyrocare Technologies Bull Case vs Bear Case — Thyrocare Technologies share price target 2026

Scenario	Price Target	Probability	Trigger
Bull Case	878	Medium	FY27 earnings beat, FII re-entry, sector re-rating
Base Case	Rs 752-878	High	FY27 in-line earnings, stable macro
Bear Case	Rs 487 zone	Low	FY27 guidance cut, prolonged FII selling

Thyrocare Technologies Share Price Reference Table

NSE Symbol	THYROCARE
CMP	Rs 627
52-Week High	Rs 928
52-Week Low	Rs 487
Market Cap	Rs 3,290 Cr
P/E	28x
Promoter	66.1%
FII	8.4%
Dividend FY26	Rs 5
Short-Term Target	Rs 752
12M Target	Rs 752-878
Upside	20-40%

Sources: NSE/BSE, Screener.in, publicly available analyst research. April 2026.

Analyst Ratings and Thyrocare Technologies share price target 2026

Brokerage	Rating	Target	Key View
MOFSL	Buy	Rs 752	FY27 earnings recovery and Diagnostics sector leadership
YES Securities	Buy	Rs 764	Quality execution — accumulate at support levels
Kotak Institutional	Add	Rs 721	Monitor Q4 FY26 guidance — maintain position
JM Financial	Neutral	Consensus	Await Q4 FY26 result clarity before adding

Subscribe to Univest Pro for SEBI-registered entry, target and stop-loss on Thyrocare Technologies.

How to Invest in Thyrocare Technologies — 5 Steps

Step 1: Research on the Univest Screener

Search THYROCARE on univest.in/screeners. Review quarterly results, FII/DII trend, promoter holding, and analyst consensus on the Thyrocare Technologies share price target 2026.

Step 2: Identify Entry Level

Thyrocare Technologies at Rs 627 has key support near Rs 487. Plan entry near support with stop-loss 8-10% below entry. First resistance toward the Thyrocare Technologies share price target 2026 recovery is Rs 752.

Step 3: Monitor Q4 FY26 Results

Q4 FY26 results (April-May 2026) are the near-term trigger. A beat with positive FY27 guidance triggers re-rating toward 878 — the bull case for the Thyrocare Technologies share price target 2026.

Step 4: Position Sizing

Allocate maximum 3-5% of your portfolio to any single stock. Never invest more than you can hold for 2+ years through volatility.

Step 5: Track on the Univest App

Download the Univest iOS App or Android App for live price alerts and SEBI-registered research aligned with the Thyrocare Technologies share price target 2026.

Conclusion — Thyrocare Technologies share price target 2026

Thyrocare Technologies (THYROCARE) at Rs 627 offers 20-40% potential upside to the 12-month Thyrocare Technologies share price target 2026 consensus of Rs 752-878. The bull case to 878 requires FY27 earnings delivery and macro normalisation. The bear case (Rs 487 zone) materialises only on significant earnings disappointment. For long-term investors with a 2-3 year horizon, Thyrocare Technologies at current levels presents a monitored entry opportunity. For more Thyrocare Technologies share price target 2026 analysis and peer comparisons, visit Univest Blogs.

Disclaimer: Investment in the share market is subject to market risks. This article is for educational and informational purposes only and does not constitute investment advice. All analyst targets are estimates based on publicly available research as of April 2026 and are subject to change. Verify all data on NSE/BSE before investing. Consult a SEBI-registered financial advisor before making any investment decisions.

Frequently Asked Questions — Thyrocare Technologies share price target 2026

Q: What is Thyrocare Technologies share price target for 2026?

The 12-month Thyrocare Technologies share price target 2026 analyst consensus is Rs 752-878 — implying 20-40% upside from CMP Rs 627. Bull case: 878. Bear case: Rs 487 zone. Track the live Thyrocare Technologies share price target 2026 on the Univest Screener. These are analyst estimates, not guaranteed returns.

Q: Is Thyrocare Technologies a good buy at Rs 627?

This article does not constitute investment advice. At Rs 627, Thyrocare Technologies offers 20-40% upside to the Thyrocare Technologies share price target 2026 consensus of Rs 752-878. Suitability depends on your risk tolerance and investment horizon. Consult a SEBI-registered financial advisor before investing.

Q: What is Thyrocare Technologies 52-week high and low?

Thyrocare Technologies’s 52-week high is Rs 928 and 52-week low is Rs 487. At the current CMP of Rs 627, the stock has corrected from its 52-week high — creating recovery potential for investors aligned with the Thyrocare Technologies share price target 2026 thesis.

Q: What sector is Thyrocare Technologies (THYROCARE) in?

Thyrocare Technologies operates in the Diagnostics / B2B Franchise / Preventive Health sector. India’s Diagnostics sector is growing structurally — driven by rising incomes, government policy, and India’s consumption expansion — underpinning the Thyrocare Technologies share price target 2026 bull case.

Q: What are the main risks for the Thyrocare Technologies share price target 2026 thesis?

Key risks: US tariff macro headwinds, valuation at 28x requiring consistent execution, competition in Diagnostics, input cost volatility, and FII selling pressure (8.4% holding). Monitor quarterly earnings closely.

Q: What is Thyrocare Technologies’s market cap?

Thyrocare Technologies has a market cap of Rs 3,290 Cr as of April 2026. At the Thyrocare Technologies share price target 2026 of Rs 752-878, the implied market cap would reflect 20-40% appreciation on the current base.

Q: What is Thyrocare Technologies dividend for FY26?

Thyrocare Technologies’s FY26 dividend is Rs 5. Track dividend announcements on NSE or the Univest Screener. Dividend yield adds to the total return alongside the Thyrocare Technologies share price target 2026 capital appreciation potential.

Q: How to buy Thyrocare Technologies shares?

Buy Thyrocare Technologies (THYROCARE) through any SEBI-registered broker on NSE. Research first on the Univest Screener, set a price alert at the Rs 487 support zone, and download the Univest App for SEBI-registered research on the Thyrocare Technologies share price target 2026.